| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new prognostic index to make short-term prognoses in MDS patients treated with azacitidine: A combination of p53 expression and cytogenetics
|
Nishiwaki, Satoshi
|
|
2016
|
41 |
C |
p. 21-26
6 p.
|
artikel
|
| 2 |
Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms
|
Sørensen, Anders Lindholm
|
|
2016
|
41 |
C |
p. 27-35
9 p.
|
artikel
|
| 3 |
BCL11A expression in acute myeloid leukemia
|
Tao, Huiquan
|
|
2016
|
41 |
C |
p. 71-75
5 p.
|
artikel
|
| 4 |
CD123 redirected multiple virus-specific T cells for acute myeloid leukemia
|
Zhou, Li
|
|
2016
|
41 |
C |
p. 76-84
9 p.
|
artikel
|
| 5 |
CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities
|
Chiaretti, Sabina
|
|
2016
|
41 |
C |
p. 36-42
7 p.
|
artikel
|
| 6 |
Editorial board and publication information
|
|
|
2016
|
41 |
C |
p. IFC-
1 p.
|
artikel
|
| 7 |
Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group
|
Ribera, Josep-Maria
|
|
2016
|
41 |
C |
p. 12-20
9 p.
|
artikel
|
| 8 |
Fludarabine-IV busulfan, dose-intensity and progression-free survival: Are we finally finding the way to reach a consensus opinion?
|
Andersson, Borje S.
|
|
2016
|
41 |
C |
p. 5-6
2 p.
|
artikel
|
| 9 |
IKZF1 (IKAROS) deletions in B-ALL and its clinical correlation: A prospective study from a tertiary care centre in Northern India
|
Gupta, Sanjeev Kumar
|
|
2016
|
41 |
C |
p. 7-11
5 p.
|
artikel
|
| 10 |
Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study
|
Itonaga, Hidehiro
|
|
2016
|
41 |
C |
p. 48-55
8 p.
|
artikel
|
| 11 |
Inhibition of glucose transporter 1 induces apoptosis and sensitizes multiple myeloma cells to conventional chemotherapeutic agents
|
Matsumoto, Taichi
|
|
2016
|
41 |
C |
p. 103-110
8 p.
|
artikel
|
| 12 |
miRNA-149* promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acute lymphoblastic leukemia
|
Fan, Sheng-jin
|
|
2016
|
41 |
C |
p. 62-70
9 p.
|
artikel
|
| 13 |
Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents
|
Nazha, Aziz
|
|
2016
|
41 |
C |
p. 43-47
5 p.
|
artikel
|
| 14 |
Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cells
|
Edwards, Shanique K.E.
|
|
2016
|
41 |
C |
p. 85-95
11 p.
|
artikel
|
| 15 |
Therapy for relapsed acute lymphoblastic leukemia: Still a role for standard chemotherapy regimens?
|
Seiter, Karen
|
|
2016
|
41 |
C |
p. 1-2
2 p.
|
artikel
|
| 16 |
The RNA binding proteins RBM38 and DND1 are repressed in AML and have a novel function in APL differentiation
|
Wampfler, Julian
|
|
2016
|
41 |
C |
p. 96-102
7 p.
|
artikel
|
| 17 |
Treatment of the older adult with ALL: An urgent call to action
|
Pullarkat, Vinod
|
|
2016
|
41 |
C |
p. 3-4
2 p.
|
artikel
|
| 18 |
Uninvolved immunoglobulins predicting hematological response in newly diagnosed AL amyloidosis
|
Muchtar, Eli
|
|
2016
|
41 |
C |
p. 56-61
6 p.
|
artikel
|
Tijdschrift beschrijving